A Research Study to Look at How a New Medicine Called NNC6019-0001 Works and How Safe it is for People Who Have Heart Disease Due to Transthyretin (TTR) Amyloidosis

Clinical trial NCT05442047 · COMPLETED

Trial details

NCT number: NCT05442047
Sponsor: Novo Nordisk A/S
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Transthyretin Amyloid Cardiomyopathy (ATTR CM)

Start date: 2022-08-02
Primary completion: 2025-02-17
Enrollment: 105

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.